Immunome Inc (IMNM)
Healthcare
Biotechnology
22.80 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Immunome Inc (IMNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -191 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -7.4 | -9.6 | -12 | -18 | -29 | -7.6 | -111 | -191 | |
| 0.5 | 0.6 | 0.8 | 0.8 | 0.6 | 0.7 | 2.1 | 3.0 | |
| 0.0 | 0.0 | 0.6 | 3.4 | 5.3 | 6.2 | 16 | 26 | |
| 0.0 | 0.0 | 6.2 | 3.0 | 5.3 | – | – | – | |
| -0.1 | 0.2 | -1.2 | 2.8 | 2.2 | 12 | 15 | -15 | |
| 0.2 | 0.2 | 0.6 | 0.1 | 0.2 | 0.8 | 54 | 9.7 | |
| -0.2 | -0.2 | -0.6 | -0.1 | -0.2 | -30 | -85 | 61 | |
| – | 4.6 | 0.0 | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | – | 0.0 | – | – | – | |
| -0.6 | -0.6 | 0.0 | -0.1 | 0.5 | – | – | – | |
| -0.6 | 11 | 50 | 28 | 0.0 | 116 | 241 | 640 | |
| -8.2 | 0.9 | 37 | 9.5 | -29 | 78 | 45 | 510 | |
| -7.6 | -9.8 | -13 | -18 | -29 | -8.4 | -164 | -201 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.